Literature DB >> 1348274

Mesencephalic dopaminergic neurons in primary cultures express functional neurotensin receptors.

A Brouard1, D Pelaprat, C Dana, M Vial, A M Lhiaubet, W Rostène.   

Abstract

The cellular distribution and functional aspects of neurotensin (NT) binding sites in rat mesencephalic cells in primary culture were investigated by an original approach combining anatomical and biochemical studies. Using a double-labeling protocol combining 125I-NT receptor radioautography and tyrosine hydroxylase (TH) immunocytochemistry, we obtained the first direct visualization of NT binding sites on TH-immunoreactive neurons. Eighty percent of the TH neurons were endowed with NT binding sites, which can be observed on both cell bodies and processes. TH-immunoreactive neurons were characterized as dopaminergic neurons by their ability to take up dopamine in a benztropine- and nomifensine-sensitive manner. In the mesencephalic cultures, NT increased potassium-evoked release of tritiated dopamine, and the relative potencies of various NT-related peptides to increase dopamine release were in good agreement with their abilities to bind to NT sites. These results show for the first time that cultured rat mesencephalic dopaminergic cells express functional NT receptors. Finally, the specificity and distribution of NT receptors on dopaminergic neurons in primary culture are quite similar to what was observed in the adult rat brain using pharmacological and radioautographic approaches. These data indicate that NT can influence the activity of dopaminergic neurons at very early stages of the rat brain development.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348274      PMCID: PMC6575810     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  11 in total

1.  Iron mediates neuritic tree collapse in mesencephalic neurons treated with 1-methyl-4-phenylpyridinium (MPP+).

Authors:  Francisco J Gómez; Pabla Aguirre; Christian Gonzalez-Billault; Marco T Núñez
Journal:  J Neural Transm (Vienna)       Date:  2010-10-02       Impact factor: 3.575

Review 2.  Neurotensin agonists: potential in the treatment of schizophrenia.

Authors:  Mona Boules; Amanda Shaw; Paul Fredrickson; Elliott Richelson
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

3.  Automatic cell culture quantitation with TRAKCELL: application to cell toxicology and differentiation.

Authors:  W Y Xu-van Opstal; C Billardon; T Caillaud; S Carvajal-Gonzalez; G Colliot; J C Bisconte; W Rostene
Journal:  Cell Biol Toxicol       Date:  1994-12       Impact factor: 6.691

4.  High affinity neurotensin receptor mRNA distribution in rat brain and peripheral tissues. Analysis by quantitative RT-PCR.

Authors:  M Méndez; F Souazé; M Nagano; P A Kelly; W Rostène; P Forgez
Journal:  J Mol Neurosci       Date:  1997-10       Impact factor: 3.444

5.  Differential binding profile and internalization process of neurotensin via neuronal and glial receptors.

Authors:  D Nouel; M P Faure; J A St Pierre; R Alonso; R Quirion; A Beaudet
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

6.  Characterization and distribution of binding sites for a new neurotensin receptor antagonist ligand, [3H]SR 48692, in the guinea pig brain.

Authors:  C Betancur; M Canton; D Gully; G Vela; D Pélaprat; W Rostène
Journal:  J Pharmacol Exp Ther       Date:  1995-06       Impact factor: 4.030

7.  Treatment of PC12 cells by nerve growth factor, dexamethasone, and forskolin. Effects on cell morphology and expression of neurotensin and tyrosine hydroxylase.

Authors:  T Caillaud; W Y Opstal; V Scarceriaux; C Billardon; W Rostene
Journal:  Mol Neurobiol       Date:  1995 Apr-Jun       Impact factor: 5.590

8.  Chromosomal localization of mouse and human neurotensin receptor genes.

Authors:  P Laurent; P Clerc; M G Mattei; P Forgez; X Dumont; P Ferrara; D Caput; W Rostene
Journal:  Mamm Genome       Date:  1994-05       Impact factor: 2.957

Review 9.  Elucidating the role of neurotensin in the pathophysiology and management of major mental disorders.

Authors:  Mona M Boules; Paul Fredrickson; Amber M Muehlmann; Elliott Richelson
Journal:  Behav Sci (Basel)       Date:  2014-06-13

10.  Diverse roles of neurotensin agonists in the central nervous system.

Authors:  Mona Boules; Zhimin Li; Kristin Smith; Paul Fredrickson; Elliott Richelson
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-22       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.